acyclovir
Generic: acyclovir
Labeler: avpakDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
avpak
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50268-061
Product ID
50268-061_47e22393-03a9-791e-e063-6294a90aa89a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075382
Listing Expiration
2027-12-31
Marketing Start
2011-03-16
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50268061
Hyphenated Format
50268-061
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA075382 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (50268-061-15) / 1 TABLET in 1 BLISTER PACK (50268-061-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e22393-03a9-791e-e063-6294a90aa89a", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["6e203fa9-ee97-1e08-8d6a-fb57cfa13e19"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (50268-061-15) / 1 TABLET in 1 BLISTER PACK (50268-061-11)", "package_ndc": "50268-061-15", "marketing_start_date": "20110316"}], "brand_name": "Acyclovir", "product_id": "50268-061_47e22393-03a9-791e-e063-6294a90aa89a", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50268-061", "generic_name": "Acyclovir", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA075382", "marketing_category": "ANDA", "marketing_start_date": "20110316", "listing_expiration_date": "20271231"}